Suchergebnisse - "Cowan, Kyra"

PubPharm (71)

21

Recommendations and discussion points on immunogenicity, biomarkers, automation/technology and protein-MS from the 2021 European Bioanalysis Forum Focus Workshops

enthalten in: Bioanalysis | 2021

von Timmerman, P. | Barfield, M. | Cowan, K. | +10

22

A strategic approach to nonclinical immunogenicity assessment : a recommendation from the European Bioanalysis Forum

enthalten in: Bioanalysis | 2021

von Laurén, A. | Goodman, J. | Blaes, J. | +8

23

Recommendations and discussion points on immunogenicity, biomarkers, automation/technology and protein–MS from the 2021 European Bioanalysis Forum Focus Workshops

enthalten in: Bioanalysis | 2021

von Timmerman, P. | Barfield, M. | Cowan, K. | +10

24

A strategic approach to nonclinical immunogenicity assessment: a recommendation from the European Bioanalysis Forum

enthalten in: Bioanalysis | 2021

von Laurén, A. | Goodman, J. | Blaes, J. | +8

25

Update to the European Bioanalysis Forum recommendation on biomarkers assays; bringing context of use into practice

enthalten in: Bioanalysis | 2020

von Goodman, J. | Cowan, K. | Golob, M. | +7

26

Translational strategies in drug development for knee osteoarthritis

enthalten in: Drug discovery today | 2020

von Cowan, K. | Kleinschmidt-Dörr, K. | Gigout, A. | +5

27

A pharmacology guided approach for setting limits on product-related impurities for bispecific antibody manufacturing

enthalten in: Journal of pharmacological and toxicological methods | 2018

von Rajan, S. | Sonoda, J. | Tully, T. | +9

28

Corrigendum to 'Effects of RG7652, a Monoclonal Antibody Against PCSK9, on Low-Density Lipoprotein Cholesterol (LDL-C), LDL-C Subfractions, and Inflammatory Biomarkers in Patients at High Risk of or with Established Coronary Heart Disease (From the Phase 2 EQUATOR Study)' The American Journal of Cardiology 119 (2017) 1576-1583

enthalten in: The American journal of cardiology | 2018

von Baruch, A. | Mosesova, S. | Davis, J. | +10

ErratumFor: Am J Cardiol. 2017 May 15;119(10):1576-1583. - PMID 28343601

29

Preclinical pharmacokinetic characterization of an adipose tissue-targeting monoclonal antibody in obese and non-obese animals

enthalten in: mAbs | 2017

von Rajan, S. | Mandikian, D. | Baruch, A. | +6

30

Recommendations for Selection and Characterization of Protein Biomarker Assay Calibrator Material

enthalten in: The AAPS journal | 2017

von Cowan, K. | Amaravadi, L. | Cameron, M. | +9